Submitted by Admin on 7 February, 2012 - 17:49
At the 23rd annual International Congress on Anti-Cancer Treatment (ICACT), which took place in Paris from 31.1. to 2.2.2012, 289 posters were presented. At the end of the congress on 2.2. the jury chose just twelve of them as best for an oral presentation. The anti-cancer preparation NSC 631570, which was developed in Austria, was represented twice among these twelve. After the oral presentations three commendations were awarded and the Austrian product was chosen as the absolute number one in combating cancer.
Deutsch
English